Jan 8 (Reuters) - Axovant Sciences Ltd:
* AXOVANT ANNOUNCES NEGATIVE RESULTS FOR INTEPIRDINE IN PHASE 2B HEADWAY AND PILOT PHASE 2 GAIT AND BALANCE STUDIES; POSITIVE TRENDS IN EFFICACY SEEN IN PILOT PHASE 2 NELOTANSERIN STUDY
* AXOVANT SCIENCES LTD - INTEPIRDINE PROGRAM TO BE DISCONTINUED BASED ON MINDSET, HEADWAY, AND GAIT AND BALANCE STUDY RESULTS Source text for Eikon: Further company coverage:
 